Back to ASND
SILVERARC CAPITAL MANAGEMENT, LLC → ASND
SILVERARC CAPITAL MANAGEMENT, LLC ASND Position History
Ascendis Pharma A/S • Healthcare
Quarters held
4
Latest value
$34.7M
Q3 2026
Peak value
$55M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $10.5M |
| Q1 2026 | $28.5M |
| Q2 2026 | $55M |
| Q3 2026 | $34.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $34.7M | 152.2K | — | — |
| Q2 2026 | $55M | 206.2K | — | — |
| Q1 2026 | $28.5M | 124.7K | — | — |
| Q4 2025 | $10.5M | 49.2K | — | — |